These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1318766)

  • 101. Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23).
    Whang-Peng J; Kao-Shan CS; Lee EC; Bunn PA; Carney DN; Gazdar AF; Minna JD
    Science; 1982 Jan; 215(4529):181-2. PubMed ID: 6274023
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Lung cancer biology.
    Carney DN; De Leij L
    Semin Oncol; 1988 Jun; 15(3):199-214. PubMed ID: 3289122
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung.
    Perry MC; Eaton WL; Propert KJ; Ware JH; Zimmer B; Chahinian AP; Skarin A; Carey RW; Kreisman H; Faulkner C
    N Engl J Med; 1987 Apr; 316(15):912-8. PubMed ID: 3029592
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Influence of surgical resection prior to chemotherapy on the long-term results in small cell lung cancer. A study of 150 operable patients.
    Osterlind K; Hansen M; Hansen HH; Dombernowsky P
    Eur J Cancer Clin Oncol; 1986 May; 22(5):589-93. PubMed ID: 3021466
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.
    Cuttitta F; Carney DN; Mulshine J; Moody TW; Fedorko J; Fischler A; Minna JD
    Nature; 1985 Aug 29-Sep 4; 316(6031):823-6. PubMed ID: 2993906
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung.
    Souhami RL; Bradbury I; Geddes DM; Spiro SG; Harper PG; Tobias JS
    Cancer Res; 1985 Jun; 45(6):2878-82. PubMed ID: 2985256
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.
    Linnoila RI; Mulshine JL; Steinberg SM; Funa K; Matthews MJ; Cotelingam JD; Gazdar AF
    Am J Clin Pathol; 1988 Dec; 90(6):641-52. PubMed ID: 2848408
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare.
    Cullen MH; Joshi R; Chetiyawardana AD; Woodroffe CM
    Br J Cancer; 1988 Sep; 58(3):359-61. PubMed ID: 2846024
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
    Rapp E; Pater JL; Willan A; Cormier Y; Murray N; Evans WK; Hodson DI; Clark DA; Feld R; Arnold AM
    J Clin Oncol; 1988 Apr; 6(4):633-41. PubMed ID: 2833577
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Preoperative and adjuvant chemotherapy in locally advanced non-small cell lung cancer.
    Kris MG; Gralla RJ; Martini N; Stampleman LV; Burke MT
    Surg Clin North Am; 1987 Oct; 67(5):1051-9. PubMed ID: 2820069
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial.
    Spiro SG; Souhami RL; Geddes DM; Ash CM; Quinn H; Harper PG; Tobias JS; Partridge M; Eraut D
    Br J Cancer; 1989 Apr; 59(4):578-83. PubMed ID: 2540788
    [TBL] [Abstract][Full Text] [Related]  

  • 112. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer.
    Dillman RO; Seagren SL; Propert KJ; Guerra J; Eaton WL; Perry MC; Carey RW; Frei EF; Green MR
    N Engl J Med; 1990 Oct; 323(14):940-5. PubMed ID: 2169587
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Longevity in small cell lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research.
    Souhami RL; Law K
    Br J Cancer; 1990 Apr; 61(4):584-9. PubMed ID: 2158807
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Are we winning the fight against cancer? An epidemiological assessment. EACR--Mühlbock memorial lecture.
    Doll R
    Eur J Cancer; 1990 Apr; 26(4):500-8. PubMed ID: 2141517
    [No Abstract]   [Full Text] [Related]  

  • 115. Increased expression of mutant forms of p53 oncogene in primary lung cancer.
    Iggo R; Gatter K; Bartek J; Lane D; Harris AL
    Lancet; 1990 Mar; 335(8691):675-9. PubMed ID: 1969059
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.
    Le Chevalier T; Arriagada R; Quoix E; Ruffie P; Martin M; Tarayre M; Lacombe-Terrier MJ; Douillard JY; Laplanche A
    J Natl Cancer Inst; 1991 Mar; 83(6):417-23. PubMed ID: 1847977
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Lung cancer.
    Souhami R
    BMJ; 1992 May; 304(6837):1298-301. PubMed ID: 1318766
    [No Abstract]   [Full Text] [Related]  

  • 118. Multidisciplinary management of lung cancer.
    Spira A; Ettinger DS
    N Engl J Med; 2004 Jan; 350(4):379-92. PubMed ID: 14736930
    [No Abstract]   [Full Text] [Related]  

  • 119. Chemotherapy in lung cancer.
    Price CG; Slevin ML
    Postgrad Med J; 1989 May; 65(763):291-8. PubMed ID: 2558370
    [No Abstract]   [Full Text] [Related]  

  • 120. Lung cancer.
    Neville A
    Clin Evid; 2003 Dec; (10):1804-23. PubMed ID: 15555176
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.